These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 22034798)

  • 1. Salivary gland and associated complications in head and neck cancer therapy.
    Kumar S; Ram S; Navazesh M
    J Calif Dent Assoc; 2011 Sep; 39(9):639-47. PubMed ID: 22034798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salivary Gland Hypofunction and Xerostomia in Head and Neck Radiation Patients.
    Jensen SB; Vissink A; Limesand KH; Reyland ME
    J Natl Cancer Inst Monogr; 2019 Aug; 2019(53):. PubMed ID: 31425600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pilocarpine during radiation therapy: results of RTOG 97-09, a phase III randomized study in head and neck cancer patients.
    Scarantino C; LeVeque F; Swann RS; White R; Schulsinger A; Hodson DI; Meredith R; Foote R; Brachman D; Lee N
    J Support Oncol; 2006 May; 4(5):252-8. PubMed ID: 16724649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of saliva in oral health: strategies for prevention and management of xerostomia.
    Brosky ME
    J Support Oncol; 2007 May; 5(5):215-25. PubMed ID: 17564151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dental management of the head and neck cancer patient treated with radiation therapy.
    Murdoch-Kinch CA; Zwetchkenbaum S
    J Mich Dent Assoc; 2011 Jul; 93(7):28-37. PubMed ID: 21888251
    [No Abstract]   [Full Text] [Related]  

  • 6. Radiation-induced xerostomia in patients with head and neck cancer: pathogenesis, impact on quality of life, and management.
    Chambers MS; Garden AS; Kies MS; Martin JW
    Head Neck; 2004 Sep; 26(9):796-807. PubMed ID: 15350026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent short-term oral complications of head and neck radiotherapy.
    Mossman KL
    Ear Nose Throat J; 1994 May; 73(5):316-20. PubMed ID: 8045235
    [No Abstract]   [Full Text] [Related]  

  • 8. The oral management of patients who have received radiotherapy to the head and neck region.
    Ray-Chaudhuri A; Shah K; Porter RJ
    Br Dent J; 2013 Apr; 214(8):387-93. PubMed ID: 23619856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using technology to decrease xerostomia for head and neck cancer patients treated with radiation therapy.
    Amosson CM; Teh BS; Mai WY; Woo SY; Chiu JK; Donovan DT; Parke R; Carpenter LS; Lu HH; Grant WH; Butler EB
    Semin Oncol; 2002 Dec; 29(6 Suppl 19):71-9. PubMed ID: 12577249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase II study to assess the efficacy of amifostine for submandibular/sublingual salivary sparing during the treatment of head and neck cancer with intensity modulated radiation therapy for parotid salivary sparing.
    Rosenthal DI; Chambers MS; Weber RS; Eisbruch A
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):25-8. PubMed ID: 15726519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiology and management of radiation-induced xerostomia.
    Berk LB; Shivnani AT; Small W
    J Support Oncol; 2005; 3(3):191-200. PubMed ID: 15915820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicity and compliance of subcutaneous amifostine in patients undergoing postoperative intensity-modulated radiation therapy for head and neck cancer.
    Thorstad WL; Chao KS; Haughey B
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):8-12. PubMed ID: 15726516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xerostomia: diagnosis and management.
    Greenspan D
    Oncology (Williston Park); 1996 Mar; 10(3 Suppl):7-11. PubMed ID: 8723427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of hyperbaric oxygenation on postradiation xerostomia and saliva in patients with head and neck tumours.
    Cankar K; Finderle Z; Jan J
    Caries Res; 2011; 45(2):136-41. PubMed ID: 21447949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of submandibular salivary gland transfer in preventing xerostomia in the chemoradiotherapy patient.
    Al-Qahtani K; Hier MP; Sultanum K; Black MJ
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Jun; 101(6):753-6. PubMed ID: 16731395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of salivary hypofunction during and after radiotherapy.
    Shiboski CH; Hodgson TA; Ship JA; Schiødt M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103 Suppl():S66.e1-19. PubMed ID: 17379158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Manifestations and treatment of xerostomia and associated oral effects secondary to head and neck radiation therapy.
    Garg AK; Malo M
    J Am Dent Assoc; 1997 Aug; 128(8):1128-33. PubMed ID: 9260423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral complications in cancer patients.
    Carl W
    Am Fam Physician; 1983 Feb; 27(2):161-70. PubMed ID: 6829371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of oral complications following radiotherapy.
    Joyston-Bechal S
    Dent Update; 1992; 19(6):232-4, 236-8. PubMed ID: 1291374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salivary Gland Hypofunction and/or Xerostomia Induced by Nonsurgical Cancer Therapies: ISOO/MASCC/ASCO Guideline.
    Mercadante V; Jensen SB; Smith DK; Bohlke K; Bauman J; Brennan MT; Coppes RP; Jessen N; Malhotra NK; Murphy B; Rosenthal DI; Vissink A; Wu J; Saunders DP; Peterson DE
    J Clin Oncol; 2021 Sep; 39(25):2825-2843. PubMed ID: 34283635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.